| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a42432b7432aac5b0a227be23fe13c26 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2015-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f9c75469864d2d83dda989a24e7f0ce |
| publicationDate |
2016-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016049385-A1 |
| titleOfInvention |
Methods and compositions for cancer treatment and treatment selection |
| abstract |
In some aspects, the disclosure provides methods of treating cancer or an infection. In some aspects, the disclosure provides methods of enhancing the efficacy of treatment with an immune checkpoint inhibitor. In some embodiments the methods comprise administering a complement inhibitor and an immune checkpoint inhibitor to a subject with cancer or an infection. In some aspects, the disclosure provides methods of identifying a subject who is an appropriate candidate for treatment with an immune checkpoint inhibitor. In some aspects, the disclosure provides methods of identifying a subject who is an appropriate candidate for treatment with an immune checkpoint inhibitor and a complement inhibitor. In some embodiments the methods comprise determining whether the subject is an appropriate candidate for treatment with an immune checkpoint inhibitor and a complement inhibitor based on an assay of a complement system biomarker in the subject or in a sample obtained from the subject. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210105270-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102401657-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10007766-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019238056-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018071668-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9920123-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10950348-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017039345-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017180815-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110831544-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2755903-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023085690-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018187813-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102395580-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11150238-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11040107-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021167177-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11278592-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11710539-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019074842-A1 |
| priorityDate |
2014-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |